Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programmeOriginal research Published on 2020-10-302024-09-04 Journal: RMD open [Category] 대상포진, [키워드] antirheumatic agents Arthritis Rheumatoid Therapeutics [DOI] 10.1136/rmdopen-2020-001395 PMC 바로가기 [Article Type] Original research
Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontlineArticle Published on 2020-10-012023-07-06 Journal: RMD Open [Category] SARS, [키워드] Arthritis Hydroxychloroquine lupus erythematosus Rheumatoid systemic [DOI] 10.1136/rmdopen-2020-001323 PMC 바로가기
Rheumatoid Arthritis in the Era of COVID-19 PandemicEditorial Published on 2020-09-212022-10-31 Journal: Mediterranean Journal of Rheumatology [Category] COVID-19, [키워드] Chloroquine Corticosteroids COVID-19 DMARDs Rheumatoid rheumatoid arthritis [DOI] 10.31138/mjr.31.3.257 PMC 바로가기 [Article Type] Editorial
Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trialRheumatoid Arthritis Published on 2020-09-012024-09-04 Journal: Annals of the rheumatic diseases [Category] 대상포진, [키워드] Arthritis Health care methotrexate outcome assessment Rheumatoid tumor necrosis factor inhibitors [DOI] 10.1136/annrheumdis-2020-217485 PMC 바로가기 [Article Type] Rheumatoid Arthritis
Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19Review Published on 2020-08-112022-10-31 Journal: Cells [Category] COVID-19, MERS, [키워드] Activation administration adverse effect blood test Clinical efficacy clinical trials COVID-19 Cytokine storm demonstrated downstream drug event Fighting highlight hyperimmune implication Infection jak inhibitors kinases management molecule outbreak Pathways Potential pro-inflammatory pro-inflammatory molecules provided reducing Rheumatoid rheumatoid arthritis risk SARS-CoV-2 Side effects Signaling signaling pathways small molecule small molecule inhibitor Small molecule inhibitors Strategy Thromboembolism Treatment tsDMARDs viral entry viral infection [DOI] 10.3390/cells9081876 PMC 바로가기 [Article Type] Review
Human Genetics in Rheumatoid Arthritis Guides a High-Throughput Drug Screen of the CD40 Signaling Pathway류마티스 관절염의 인간 유전학은 CD40 신호 전달 경로의 고처리량 약물 검사를 안내합니다Research Article Published on 2013-05-162022-09-06 Journal: PLoS Genetics [Category] Communicable Disease, [키워드] activated After allele Analysis approved drug Arthritis association Author B cells B lymphocyte B lymphocytes Biology can be used CD19+ CD40 CD40 ligand CD40 signaling Cell cell line chemical compounds clinical care coding Combination complex Compound consequence controls correlation counter deep sequencing develop disease drug Drug discovery drugs effort eQTL ExoN exonic explain expression finding Follow-up gain-of-function Genetic genetic findings Genome-wide association studies Genome-wide association study genotyping guide GWAS healthy control homozygous Human Human genetics identify implicated increase individuals Infection Inflammation inhibit inhibitor loci locus lymphocyte Lymphocytes mononuclear cell mononuclear cells mouse NF-kB NF-κB NF-κB signaling non-risk allele observé p65 pathway Patient Peripheral blood Peripheral blood mononuclear cells Phosphorylation Protein Quantitative RA RELA reporter retroviral Rheumatoid rheumatoid arthritis risk risk allele Screen second Sequencing seropositive Signaling single SNP small molecule Small molecules small-molecule screen subject subunit therapy trait traits transcription factor treat variant while [DOI] 10.1371/journal.pgen.1003487 PMC 바로가기 [Article Type] Research Article